This is the authors' abstract. We don't add key points for this paper.
Background: This study investigated the effects of endurance exercise training and zoledronic acid (Zol) treatment on ovariectomy-induced osteopenia. Methods: Middle-aged female Wistar rats were subjected to sham and ovariectomy surgeries and assigned to seven different groups according to Zol treatment doses and treadmill endurance exercise training; these were the Sham, Ovx, LowZ, HighZ, EXE, LowZ+EXE, HighZ+EXE groups. The subcutaneous (s.c.) doses of Zol for the LowZ and HighZ groups were 20 and 100 µg/kg, respectively. Total intervention period was 10 weeks. Results: Both Zol treatment and exercise training significantly blunted ovariectomy-induced osteopenia in spongy bone (p<0.05). Zol treatments increased whole bone bending strength/energy as well as tissue-level toughness (p<0.05). The EXE and LowZ+EXE had higher levels of serum phosphorus as compared to other groups, suggesting higher bone metabolism activity. Additionally, the three exercise groups’ significantly lower serum triglycerides, leptin, IGF-1 and IGF-1/IGFBP-3 molar ratio, along with increased IGFBP-3. Conclusions: Though exercise training did not demonstrate significantly synergistic or modifying effects to Zol-treated bone, results from energy, aging and bone related serum measurements indicate that exercise might reveal its benefits in later phases or at lower doses of bisphosphonate.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: